We are here ready to support Health Medicine with free home delivery.

Email Address

support@clinicalinks.com

Phone Number

(+62) 8152 254 239

Our Location

Jl. Sunset Road No.815

$16.99

moBRCA-net for Breast Cancer Subtype Classification

This paper introduces moBRCA-net, an interpretable deep learning framework for breast cancer subtype classification using multi-omics data. By integrating gene expression, DNA methylation, and microRNA expression with omics-level attention mechanisms, the model achieves significantly improved classification performance over existing methods.

Share :

Additional Information

Author Joung Min Choi, Heejoon Chae
Research Type Multi-Omics Integration
Pages 15
Language English

Description

Breast cancer is a biologically heterogeneous disease that requires accurate molecular subtype classification to support prognosis assessment and treatment planning. This research presents moBRCA-net, a deep learning–based breast cancer subtype classification framework designed to integrate multi-omics data while maintaining interpretability.

The proposed method combines gene expression, DNA methylation, and microRNA expression data collected from The Cancer Genome Atlas. A biologically informed feature selection strategy is applied to preserve relationships across omics layers, followed by an omics-level self-attention mechanism that learns the relative importance of each molecular feature. The transformed representations are then used for subtype prediction through fully connected neural network layers.

Experimental results demonstrate that moBRCA-net significantly outperforms traditional machine learning classifiers and state-of-the-art deep learning models. The framework achieves high accuracy, F1-score, and Matthews correlation coefficient, particularly when all three omics datasets are integrated. Additional analyses confirm that attention mechanisms improve model focus on biologically meaningful features and enhance interpretability.

This research is highly relevant for bioinformatics researchers, cancer genomics specialists, and medical AI practitioners. It provides a robust and interpretable framework for multi-omics integration in molecular cancer subtype classification.